Multicenter registry of Impella-assisted high-risk percutaneous coronary interventions and cardiogenic shock in Poland (IMPELLA-PL)

被引：0

作者：

Pietrasik, Arkadiusz ^{[1
,23
]}

Gasecka, Aleksandra ^{[1
]}

Pawlowski, Tomasz ^{[2
]}

Sacha, Jerzy ^{[3
,4
]}

Grygier, Marek ^{[5
]}

Bielawski, Gabriel ^{[6
]}

Balak, Wojciech ^{[6
]}

Sukiennik, Adam ^{[7
]}

Burzynska, Paulina ^{[7
]}

Witkowski, Adam ^{[8
]}

Warniello, Mateusz ^{[8
]}

Rzeszutko, Lukasz ^{[9
]}

Bartus, Stanislaw ^{[9
]}

Pawlik, Artur ^{[9
]}

Kaczynski, Mateusz ^{[4
]}

Gil, Robert ^{[4
]}

Kuliczkowski, Wiktor ^{[10
]}

Reczuch, Krzysztof ^{[10
]}

Protasiewicz, Marcin ^{[10
]}

Kleczynski, Pawel ^{[11
]}

Wanczura, Piotr ^{[12
]}

Gurba, Sebastian ^{[12
]}

Kochanowska, Anna ^{[1
,13
]}

Lomiak, Michal ^{[1
]}

Cacko, Andrzej ^{[1
]}

Skorupski, Wlodzimierz ^{[5
]}

Zarebinski, Maciej

Pawluczuk, Piotr

Wlodarczak, Szymon ^{[14
]}

Wlodarczak, Adrian ^{[14
]}

Sciborski, Krzysztof ^{[15
]}

Telichowski, Artur ^{[15
]}

Plucinski, Mieszko ^{[16
,17
]}

Hiczkiewicz, Jaroslaw ^{[16
,17
]}

Konsek, Karolina

Hawranek, Michal

Gasior, Mariusz ^{[18
]}

Peruga, Jan ^{[19
]}

Fiutowski, Marcin ^{[19
]}

Romanek, Robert ^{[20
]}

Kasprzyk, Piotr ^{[21
]}

Ciecwierz, Dariusz ^{[21
]}

Ochala, Andrzej ^{[22
]}

Wojakowski, Wojciech ^{[22
]}

Legutko, Jacek

Kochman, Janusz ^{[1
]}

机构：

[1] Med Univ Warsaw, Dept Cardiol, Warsaw, Poland

[2] Minist Interior & Adm, Natl Med Inst, Warsaw, Poland

[3] Opole Univ Technol, Fac Phys Educ & Physiotherapy, Opole, Poland

[4] Univ Hosp Opole, Dept Cardiol, Opole, Poland

[5] Poznan Univ Med Sci, Dept Cardiol 1, Poznan, Poland

[6] Nicolaus Copernicus Univ Torun, Jan Biziel Univ Hosp 2, Coll Med Bydgoszcz, Dept Cardiol 2, Torun, Poland

[7] Nicolaus Copernicus Univ Torun, Univ Hosp 1, Coll Med Bydgoszcz, Dept Cardiol & Internal Dis, Torun, Poland

[8] Natl Inst Cardiol, Dept Intervent Cardiol & Angiol, Warsaw, Poland

[9] Univ Hosp, Dept Cardiol, Krakow, Poland

[10] Wroclaw Med Univ, Dept Heart Dis, Wroclaw, Poland

[11] Jagiellonian Univ Med Coll, John Paul II Hosp, Inst Cardiol, Dept Intervent Cardiol, Krakow, Poland

[12] Univ Rzeszow, Coll Med Sci, Rzeszow, Poland

[13] Independent Publ Specialist Western Hosp John Paul, Grodzisk Mazowiecki, Poland

[14] Copper Hlth Ctr, Dept Cardiol, Lubin, Poland

[15] Mil Hosp Wroclaw, Ctr Heart Dis, Wroclaw, Poland

[16] Univ Zielona Gora, Coll Med, Dept Intervent Cardiol & Cardiac Surg, Zielona Gora, Poland

[17] Nowa Sol Multidisciplinary Hosp, Dept Cardiol, Nowa Sol, Poland

[18] Med Univ Silesia, Fac Med Sci Zabrze, Dept Cardiol 3, Katowice, Poland

[19] Med Univ Lodz, Bieganski Hosp, Dept Cardiol 1, Lodz, Poland

[20] 10 Mil Hosp & Polyclin, Dept Cardiol & Cardiac Surg, Bydgoszcz, Poland

[21] Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland

[22] Med Univ Silesia, Dept Cardiol & Struct Heart Dis, Katowice, Poland

[23] Med Univ Warsaw, Chair & Dept Cardiol 1, Banacha 1A, PL-02097 Warsaw, Poland

来源：

KARDIOLOGIA POLSKA | 2023年 / 81卷 / 11期

关键词：

cardiogenic shock; high risk-percutaneous coronary intervention; Impella; mechanical circulatory support; ST-segment elevation myocardial infarction; MECHANICAL CIRCULATORY SUPPORT; RANDOMIZED CLINICAL-TRIAL; INTRAAORTIC BALLOON; HEMODYNAMIC SUPPORT; TASK-FORCE; OUTCOMES; DEVICE; GUIDELINES; PUMP;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Impella is a percutaneous mechanical circulatory support device for treatment of cardiogenic shock (CS) and high-risk percutaneous coronary interventions (HR-PCIs). IMPELLA-PL is a national retrospective registry of Impellatreated CS and HR-PCI patients in 20 Polish interventional cardiological centers, conducted from January 2014 until December 2021.Aims: We aimed to determine the efficacy and safety of Impella using real-world data from IMPELLA--PLand compare these with other registries.Methods: IMPELLA-PL data were analyzed to determine primary endpoints: in-hospital mortality and rates of mortality and major adverse cardiovascular and cerebrovascular events (MACCE) at 12 months post-discharge.Results: Of 308 patients, 18% had CS and 82% underwent HR-PCI. In-hospital mortality rates were 76.4% and 8.3% in the CS and HR-PCI groups, respectively. The 12-month mortality rates were 80.0% and 18.2%, and post-discharge MACCE rates were 9.1% and 22.5%, respectively. Any access site bleeding occurred in 30.9% of CS patients and 14.6% of HR-PCI patients, limb ischemia in 12.7% and 2.4%, and hemolysis in 10.9% and 1.6%, respectively.Conclusions: Impella is safe and effective during HR-PCIs, in accordance with previous registry analyses. The risk profile and mortality in CS patients were higher than in other registries, and the potential benefits of Impella in CS require investigation.

引用

页码：1103 / 1112

页数：10

共 50 条

[1] Observational, multicenter registry of Impella-assisted high-risk percutaneous coronary interventions and cardiogenic shock in Poland (IMPELLA-PL): efficacy and safety outcomes
Pietrasik, A.
Gasecka, A.
Sacha, J.
Pawlowski, T.
Grygier, M.
Bielawski, G.
Sukiennik, A.
Witkowski, A.
Bartus, S.
Cacko, A.
Gil, R.
Kuliczkowski, W.
Wanczura, P.
Legutko, J.
Kochman, J.
[J]. EUROPEAN HEART JOURNAL, 2023, 44
[2] Mechanical circulatory support for high-risk percutaneous coronary interventions and cardiogenic shock: Rationale and design of the multicenter, investigator-initiated IMPELLA-PL registry
Pietrasik, Arkadiusz
Gasecka, Aleksandra
Grygier, Marek
Pawlowski, Tomasz
Sacha, Jerzy
Kochman, Janusz
[J]. CARDIOLOGY JOURNAL, 2022, 29 (05) : 866 - 871
[3] Sex, Age, and Shock: Impella-Assisted High-Risk Percutaneous Coronary Intervention
Bimal, T.
Fishbein, J.
Miklin, D.
Gandotra, P.
Omar, W.
Ong, L.
Gruberg, L.
[J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (04) : S3 - S3
[4] Impella-Assisted Complex High-Risk Percutaneous Coronary Intervention
Lin, Yen-Po
Lee, Wen-Lieng
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (16) : S208 - S210
[5] Impella-assisted chronic total occlusion percutaneous coronary interventions: A multicenter retrospective analysis
Riley, Robert F.
McCabe, James M.
Kalra, Sanjog
Lazkani, Mohamad
Pershad, Ashish
Doshi, Darshan
Kirtane, Ajay J.
Nicholson, William
Kearney, Katherine
Demartini, Tony
Grantham, J. Aaron
Moses, Jeffrey
Lombardi, William
Karmpaliotis, Dimitri
[J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (07) : 1261 - 1267
[6] Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization
Tarantini, Giuseppe
Masiero, Giulia
Burzotta, Francesco
Pazzanese, Vittorio
Briguori, Carlo
Trani, Carlo
Piva, Tommaso
De Marco, Federico
Di Biasi, Maurizio
Pagnotta, Paolo
Mojoli, Marco
Casu, Gavino
Giustino, Gennaro
Lorenzoni, Giulia
Montorfano, Matteo
Ancona, Marco B.
Pappalardo, Federico
Chieffo, Alaide
[J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 98 (02) : E222 - E234
[7] Hybrid Robotic Impella-Assisted Single Arterial Access Complex High-Risk Percutaneous Coronary Intervention
Nagaraja, Vinayak
Khatri, Jaikirshan J.
[J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2020, 21 (11) : S105 - S107
[8] The Impact of Age in Patients Undergoing Impella-Assisted High-Risk Percutaneous Coronary Intervention: It Gets Complicated
Bimal, Tia
Ukrani, Janta
Fishbein, Joanna
Selim, Samy
Gandotra, Puneet
Ong, Lawrence
Gruberg, Luis
[J]. CIRCULATION, 2023, 148
[9] Peripheral intravascular lithotripsy paving the way for Impella-assisted multivessel high-risk percutaneous coronary revascularization
Paszek, Elzbieta
Niewiara, Lukasz
Szolc, Piotr
Baran, Jakub
Rzeznik, Daniel
Welgan, Katarzyna
Kwiatkowska, Ewa
Legutko, Jacek
Kleczynski, Pawel
[J]. KARDIOLOGIA POLSKA, 2023, 81 (7-8) : 781 - 783
[10] Impella support for cardiogenic shock and high-risk percutaneous coronary intervention: A single-center experience
Brandao, Mariana
Caeiro, Daniel
Pires-Morais, Gustavo
Almeida, Joao Goncalves
Teixeira, Pedro Goncalves
Silva, Marisa Passos
Ponte, Marta
Dias, Adelaide
Oliveira, Marco
Rodrigues, Alberto
Braga, Pedro
[J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2021, 40 (11) : 853 - 861

← 1 2 3 4 5 →